{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:50:54Z","timestamp":1791183054567,"version":"4.1.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Efficacy and Mechanism Evaluation"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>STUDY QUESTION<\/jats:title>\n                    <jats:p>Does preconceptual doxycycline prevent miscarriage in women with recurrent miscarriage (RM) and chronic endometritis (CE) defined by CD138+ stromal cells?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUMMARY ANSWER<\/jats:title>\n                    <jats:p>Preconceptual doxycycline was not associated with improved livebirth rates in women with CE and a history of RM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                    <jats:p>CE is characterised by asymptomatic endometrial inflammation and has been associated with RM. Some national and international RM guidelines advise testing and treating for CE with antibiotics, most commonly doxycycline, whereas others do not.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                    <jats:p>Definitions of CE vary widely; in this study, all CD138+ cells, not only morphological plasma cells were included in the assessment. This was an adaptive, multi-centre, parallel-arm, double-blind, placebo-controlled, randomised trial. Recruitment started on January 2020, and follow-up finished on October 2023. Of 2178 women screened, 505 were positive for CD138 and 438 were randomised. A subgroup (202) had repeat endometrial biopsies in the luteal phase of their treatment cycle analysed. A screen negative group (208) were followed up in their first pregnancies. Screen positive women were randomised using an online web tool to preconceptual doxycycline 100\u2009mg or an identical placebo from day 1 of the menstrual cycle, twice daily for 14\u2009days. Patients, their clinicians and outcome assessors were blinded to treatment allocation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                    <jats:p>Women, aged \u226518 to &amp;lt;42\u2009years with \u22652 consecutive first trimester miscarriages were recruited in specialist RM clinics from 27 UK sites. Screening was by luteal phase endometrial biopsy with immunohistochemistry for CD138. The primary outcome was cumulative live birth and pregnancies \u226524\u2009+\u20090\u2009weeks gestation at cessation of the trial. Secondary outcomes included first pregnancy outcome, time to first conception and pregnancy complication rates. A prospective Bayesian analysis with no prior information was undertaken to estimate posterior probabilities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                    <jats:p>There were 113\/219 (52%) cumulative livebirths or ongoing pregnancies in the doxycycline group and 109\/219 (50%) in the placebo group (adjusted Relative Risk (aRR)1.02; Credible Interval (CrI) 0.85\u20131.21). Sensitivity analysis did not influence these results. In the CE negative group, there were 62\/208 (30%) livebirths or ongoing first pregnancies compared to 89\/219 (41%) in the placebo group (aRR 0.73; CrI 0.56\u20130.95). The amount and pattern of CD138 staining varied equally before and after placebo (98 paired biopsies) and doxycycline (104 paired biopsies) treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                    <jats:p>In keeping with the adaptive Bayesian design, the trial was stopped at interim analyses. Whilst a higher-than-expected prevalence of CD138+ CE occurred in this study, a sensitivity analysis increasing the diagnostic threshold did not alter the findings. The second biopsies occurred within the treatment menstrual cycle; hence, we did not exclude a difference in CD138+ CE after menstruation. A few participants obtained additional doxycycline; however, a sensitivity analysis excluding these showed no difference in outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                    <jats:p>Neither the primary nor secondary outcome measures supported the use of doxycycline in the management of CD138+ CE in this first placebo-controlled trial. Similar differences in CD138 expression before and after placebo or doxycycline suggesting inter-cycle variation may account for previously reported findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>FUNDING<\/jats:title>\n                    <jats:p>This study was funded by the Efficacy and Mechanism Evaluation Programme, a Medical Research Council (MRC) and National Institute for Health and Care Research (NIHR) partnership (Funder reference: 17\/60\/22).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DISCLOSURES<\/jats:title>\n                    <jats:p>All authors declare no competing interests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                    <jats:p>ISRCTN 2394773 https:\/\/doi.org\/10.1186\/ISRCTN23947730<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION DATE<\/jats:title>\n                    <jats:p>12 September 2019<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATE OF FIRST PATIENT\u2019S ENROLMENT<\/jats:title>\n                    <jats:p>3 January 2020<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/humrep\/deag133","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:16:31Z","timestamp":1785323791000},"page":"1661-1671","source":"Crossref","is-referenced-by-count":0,"title":["A double-blind multi-centre randomised placebo-controlled trial of doxycycline in women with recurrent miscarriage and chronic endometritis defined by CD138 positive stromal cells"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7829-3729","authenticated-orcid":false,"given":"J","family":"Odendaal","sequence":"first","affiliation":[{"name":"Division of Biomedical Sciences, Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick , Coventry,","place":["UK"]},{"name":"University Hospitals Coventry & Warwickshire , Coventry,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Black","sequence":"additional","affiliation":[{"name":"Division of Biomedical Sciences, Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick , Coventry,","place":["UK"]},{"name":"University Hospitals Coventry & Warwickshire , Coventry,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Fishwick","sequence":"additional","affiliation":[{"name":"Division of Biomedical Sciences, Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick , Coventry,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Thornton","sequence":"additional","affiliation":[{"name":"Division of Biomedical Sciences, Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick , Coventry,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Makwana","sequence":"additional","affiliation":[{"name":"Division of Biomedical Sciences, Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick , Coventry,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Ewington","sequence":"additional","affiliation":[{"name":"Division of Biomedical Sciences, Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick , Coventry,","place":["UK"]},{"name":"University Hospitals Coventry & Warwickshire , Coventry,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Larsen","sequence":"additional","affiliation":[{"name":"Division of Biomedical Sciences, Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick , Coventry,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Hawkes","sequence":"additional","affiliation":[{"name":"Division of Biomedical Sciences, Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick , Coventry,","place":["UK"]},{"name":"University Hospitals Coventry & Warwickshire , Coventry,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Leeson","sequence":"additional","affiliation":[{"name":"Division of Biomedical Sciences, Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick , Coventry,","place":["UK"]},{"name":"University Hospitals Coventry & Warwickshire , Coventry,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Fisher","sequence":"additional","affiliation":[{"name":"Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick , Coventry,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Lall","sequence":"additional","affiliation":[{"name":"Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick , Coventry,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Guck","sequence":"additional","affiliation":[{"name":"Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick , Coventry,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Coomarasamy","sequence":"additional","affiliation":[{"name":"Tommy\u2019s National Centre for Miscarriage Research, Nuffield Department of Women\u2019s and Reproductive Health, Medical Sciences Division, University of Oxford , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7056-5723","authenticated-orcid":false,"given":"I","family":"Granne","sequence":"additional","affiliation":[{"name":"Nuffield Department of Women\u2019s and Reproductive Health, Medical Sciences Division, University of Oxford , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Underwood","sequence":"additional","affiliation":[{"name":"University Hospitals Coventry & Warwickshire , Coventry,","place":["UK"]},{"name":"Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick , Coventry,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Bouliotis","sequence":"additional","affiliation":[{"name":"Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick , Coventry,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3221-5471","authenticated-orcid":false,"given":"S","family":"Quenby","sequence":"additional","affiliation":[{"name":"Division of Biomedical Sciences, Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick , Coventry,","place":["UK"]},{"name":"University Hospitals Coventry & Warwickshire , Coventry,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"2026100501520147300_deag133-B1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humrep\/deu292","article-title":"Prevalence of chronic endometritis in repeated unexplained implantation failure and the IVF success rate after antibiotic therapy","volume":"30","author":"Cicinelli","year":"2015","journal-title":"Hum Reprod"},{"key":"2026100501520147300_deag133-B2","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1177\/1933719113508817","article-title":"Chronic endometritis due to common bacteria is prevalent in women with recurrent miscarriage as confirmed by improved pregnancy outcome after antibiotic treatment","volume":"21","author":"Cicinelli","year":"2014","journal-title":"Reprod Sci"},{"key":"2026100501520147300_deag133-B3","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJMoa1813730","article-title":"A randomized trial of progesterone in women with bleeding in early pregnancy","volume":"380","author":"Coomarasamy","year":"2019","journal-title":"N Engl J Med"},{"key":"2026100501520147300_deag133-B4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41572-020-00228-z","article-title":"Recurrent pregnancy loss","volume":"6","author":"Dimitriadis","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2026100501520147300_deag133-B5","doi-asserted-by":"crossref","first-page":"hoad002","DOI":"10.1093\/hropen\/hoad002","article-title":"ESHRE guideline: recurrent pregnancy loss: an update in 2022","volume":"2023","author":"ESHRE Guideline Group on RPL","year":"2023","journal-title":"Hum Reprod Open"},{"key":"2026100501520147300_deag133-B6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/uog.23147","article-title":"Differences in post-traumatic stress, anxiety and depression following miscarriage or ectopic pregnancy between women and their partners: multicenter prospective cohort study","volume":"57","author":"Farren","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2026100501520147300_deag133-B7","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.rbmo.2021.02.014","article-title":"Clinical practice guidelines for recurrent miscarriage in high-income countries: a systematic review","volume":"42","author":"Hennessy","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"2026100501520147300_deag133-B8","doi-asserted-by":"crossref","first-page":"103146","DOI":"10.1016\/j.jri.2020.103146","article-title":"Variation of diagnostic criteria in women with chronic endometritis and its effect on reproductive outcomes: a systematic review and meta-analysis","volume":"140","author":"Huang","year":"2020","journal-title":"J Reprod Immunol"},{"key":"2026100501520147300_deag133-B9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejogrb.2016.02.015","article-title":"Pregnancy loss: French clinical practice guidelines","volume":"201","author":"Huchon","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2026100501520147300_deag133-B10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.fertnstert.2008.12.131","article-title":"Chronic endometritis is a frequent finding in women with recurrent implantation failure after in vitro fertilization","volume":"93","author":"Johnston-MacAnanny","year":"2010","journal-title":"Fertil Steril"},{"key":"2026100501520147300_deag133-B11","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12719","article-title":"Live birth rate following oral antibiotic treatment for chronic endometritis in infertile women with repeated implantation failure","volume":"78","author":"Kitaya","year":"2017","journal-title":"Am J Reprod Immunol"},{"key":"2026100501520147300_deag133-B12","doi-asserted-by":"crossref","first-page":"980511","DOI":"10.3389\/fmed.2022.980511","article-title":"Impact of antibiotic treatment for chronic endometritis on pregnancy outcomes in women with reproductive failures (RIF and RPL): a systematic review and meta-analysis","volume":"9","author":"Liu","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2026100501520147300_deag133-B13","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.fertnstert.2018.01.022","article-title":"Comparison of the prevalence of chronic endometritis as determined by means of different diagnostic methods in women with and without reproductive failure","volume":"109","author":"Liu","year":"2018","journal-title":"Fertil Steril"},{"key":"2026100501520147300_deag133-B14","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.fertnstert.2013.12.031","article-title":"Chronic endometritis in women with recurrent early pregnancy loss and\/or fetal demise","volume":"101","author":"McQueen","year":"2014","journal-title":"Fertil Steril"},{"key":"2026100501520147300_deag133-B15","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.fertnstert.2015.06.044","article-title":"Pregnancy outcomes in women with chronic endometritis and recurrent pregnancy loss","volume":"104","author":"McQueen","year":"2015","journal-title":"Fertil Steril"},{"key":"2026100501520147300_deag133-B16","doi-asserted-by":"crossref","first-page":"e13482","DOI":"10.1111\/aji.13482","article-title":"Treatment following hysteroscopy and endometrial diagnostic biopsy increases the chance for live birth in women with chronic endometritis","volume":"86","author":"Mitter","year":"2021","journal-title":"Am J Repro Immunol"},{"key":"2026100501520147300_deag133-B17","doi-asserted-by":"crossref","first-page":"602.e1","DOI":"10.1016\/j.ajog.2018.02.012","article-title":"The diagnosis of chronic endometritis in infertile asymptomatic women: a comparative study of histology, microbial cultures, hysteroscopy, and molecular microbiology","volume":"218","author":"Moreno","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"2026100501520147300_deag133-B18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.rbmo.2020.12.009","article-title":"The challenges of trials in reproductive medicine: can a Bayesian approach help?","volume":"42","author":"Odendaal","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"2026100501520147300_deag133-B19","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/humrep\/dead274","article-title":"The endometrial microbiota and early pregnancy loss","volume":"39","author":"Odendaal","year":"2024","journal-title":"Hum Reprod"},{"key":"2026100501520147300_deag133-B20","doi-asserted-by":"crossref","first-page":"e081470","DOI":"10.1136\/bmjopen-2023-081470","article-title":"Preconceptual administration of doxycycline in women with recurrent miscarriage and chronic endometritis: protocol for the Chronic Endometritis and Recurrent Miscarriage (CERM) trial, a multicentre, double-blind, placebo-controlled, adaptive randomised trial","volume":"13","author":"Odendaal","year":"2023","journal-title":"BMJ Open"},{"key":"2026100501520147300_deag133-B21","first-page":"699","author":"Odendaal","year":"2026"},{"key":"2026100501520147300_deag133-B22","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.fertnstert.2012.06.048","article-title":"Evaluation and treatment of recurrent pregnancy loss: a committee opinion","volume":"98","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2012","journal-title":"Fertil Steril"},{"key":"2026100501520147300_deag133-B23","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.fertnstert.2012.06.050","article-title":"The clinical relevance of luteal phase deficiency: a committee opinion","volume":"98","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2012","journal-title":"Ferti Steril"},{"key":"2026100501520147300_deag133-B24","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(21)00682-6","article-title":"Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss","volume":"397","author":"Quenby","year":"2021","journal-title":"Lancet"},{"key":"2026100501520147300_deag133-B25","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1111\/1471-0528.17515","article-title":"Recurrent MiscarriageGreen-top Guideline No. 17","volume":"130","author":"Regan","year":"2023","journal-title":"BJOG"},{"key":"2026100501520147300_deag133-B26","doi-asserted-by":"crossref","first-page":"104456","DOI":"10.1016\/j.rbmo.2024.104456","article-title":"The investigation and management of recurrent early pregnancy loss: a Canadian Fertility and Andrology Society clinical practice guideline","volume":"50","author":"Sierra","year":"2025","journal-title":"Reprod Biomed Online"},{"key":"2026100501520147300_deag133-B27","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.fertnstert.2020.12.019","article-title":"Impact of antibiotic therapy on the rate of negative test results for chronic endometritis: a prospective randomized control trial","volume":"115","author":"Song","year":"2021","journal-title":"Fertil Steril"},{"key":"2026100501520147300_deag133-B28","volume-title":"Bayesian Approaches to Clinical Trials and Health-Care Evaluation","author":"Spiegelhalter","year":"2004"},{"key":"2026100501520147300_deag133-B29","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/ajo.13821","article-title":"Australasian recurrent pregnancy loss clinical management guideline 2024 Part I","volume":"64","author":"Suker","year":"2024","journal-title":"Aust N Zea J Obstet Gynaecol"},{"key":"2026100501520147300_deag133-B30","doi-asserted-by":"crossref","first-page":"1427454","DOI":"10.3389\/fimmu.2024.1427454","article-title":"Chronic endometritis and recurrent reproductive failure: a systematic review and meta-analysis","volume":"15","author":"Ticconi","year":"2024","journal-title":"Front Immunol"},{"key":"2026100501520147300_deag133-B31","first-page":"49","article-title":"Recurrent miscarriage: diagnostic and therapeutic procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No.\u2009015\/050, May 2022)","volume":"83","author":"Toth","year":"2022","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"2026100501520147300_deag133-B32","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/jama.2023.14111","article-title":"Futility in clinical trials","volume":"330","author":"Wendelberger","year":"2023","journal-title":"JAMA"},{"key":"2026100501520147300_deag133-B33","volume-title":"Clinical Trial Design: Bayesian and Frequentist Adaptive Methods","author":"Yin","year":"2012"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/41\/10\/1661\/70717045\/deag133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/41\/10\/1661\/70717045\/deag133.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:52:13Z","timestamp":1791179533000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/41\/10\/1661\/8766800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":33,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,8,20]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deag133","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,8,20]]}}}